Philadelphia, May 27, 2022 —Researchers with the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) will present a wide range of study results at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago and online June 3-7. The data include evaluations of new approaches to cancer treatment, control, care delivery, and health equity. The National Cancer Institute, part of the National Institutes of Health, funded these studies.
Contact:
Diane Dragaud
Director of Communications
(215) 789-3631
Inquire and request an interview by email
About the ECOG-ACRIN Cancer Research Group
The ECOG-ACRIN Cancer Research Group is a membership-based scientific organization that designs and conducts cancer research involving adults who have or are at risk of developing cancer. ECOG-ACRIN comprises nearly 1300 member institutions in the United States and around the world. Approximately 15,000 physicians, translational scientists, and associated research professionals from the member institutions are involved in Group research across three scientific programs: Cancer Control and Outcomes, Therapeutic Studies, and Biomarker Sciences. ECOG-ACRIN is supported primarily through National Cancer Institute research grant funding but also receives funding from private sector organizations through philanthropy and collaborations. Its headquarters are in Philadelphia, Pa. Visit www.ecog-acrin.org and follow us on Twitter @eaonc, Facebook, and LinkedIn.
# # #